Schizophrenia and Related Disorders Alliance of America
This story appears to have been written by the PR department of the company that makes Invega- the first once-monthly atypicle antipsychotic approved for Schizophrenia in the United States.
Link to full article
Submitted by: Darrell H.
Powered by Robly™
Copyright © 2008-2017 SARDAA · All Rights Reserved.